Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
Alzheimer’s Disease: Eight-Market Drug Forecast and Market Analysis
... the Alzheimer’s Disease (AD) market in the 8MM in 2023 was $2.4 billion. This market is defined as sales of symptamatic and disease modifying (DMT) treatments including approval of anti-Aβmonoclonal antibodies (mAbs) across the 8MM ... Read More
-
2025 Global Alzheimer'S Disease Drug Market Industry (2031 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written ... Read More
-
Alzheimer’s Disease: 68-Market Analysis and Sales Forecast
... Alzheimer’s Disease (AD) market in the 8MM in 2023 was $2.4 billion. This market is defined as sales of symptamatic and disease modifying (DMT) treatments including approval of anti-Aβmonoclonal antibodies (mAbs) across the 8MM.he US ... Read More
-
Global Alzheimer's Disease Drug Market Growth 2025-2031
... to 2031. Alzheimer"s disease (AD), also referred to simply as Alzheimer"s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of ... Read More
-
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
... the diagnostic market covers only biomarker tests for AD. Cognitive tests and neuroimaging diagnostic methods assessing structural changes are not part of the market calculations. The diagnostics market segmentation is based on the test type ... Read More
-
Active Wheelchair Market Size, Share & Trends Analysis Report By Type (Manual Wheelchair, Powered Wheelchair), By Indication (Alzheimer's Disease, Cerebral Palsy), By Region, And Segment Forecasts, 2025 - 2030
... The global active wheelchair market size is expected to reach USD 2.32 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Surge ... Read More
-
Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... a CAGR of 5.81% during the forecast period 2024-2032. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The market study has also analyzed the impact ... Read More
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... market was valued at $2551.32 million in 2023 and is expected to reach a revenue of $4237.32 million by 2032. MARKET INSIGHTS The United States Alzheimer’s disease therapeutics & diagnostics industry is growing rapidly, escalated ... Read More
-
Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... at $2105.39 million in 2023 and is expected to reach a revenue of $3594.76 million by 2032. MARKET INSIGHTS The Europe Alzheimer's disease therapeutics & diagnostics market is experiencing substantial growth due to the rising ... Read More
-
Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... at $1686.32 million in 2023 and is expected to reach a revenue of $2905.83 million by 2032. MARKET INSIGHTS The Asia-Pacific Alzheimer's disease therapeutics & diagnostics market is experiencing substantial growth, driven by the rising ... Read More
-
North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... was valued at $2941.34 million in 2023 and is expected to reach a revenue of $4825.00 million by 2032. MARKET INSIGHTS The North America Alzheimer's disease therapeutics & diagnostics market is expanding due to several ... Read More
-
Global Alzheimer's Disease Therapeutics and Diagnostics Market Growth (Status and Outlook) 2024-2030
... in 2023. With growing demand in downstream market, the Alzheimer's Disease Therapeutics and Diagnostics is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The ... Read More
-
Global Brahmi Market 2024-2028
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Global Acetylcholinesterase Inhibitors Market - 2024-2031
... forecast period 2024-2031. Acetylcholinesterase inhibitors (AChEIs) are a specific kind of drug that is essential in the treatment of a variety of neurological illnesses, including Alzheimer's disease and other forms of dementia. These medications work ... Read More
-
Citicoline Market Research Report Information by Product (Capsules, Tablets, Powder, Eye Drops, and Injection) by Application (Sports Nutrition, Personal Wellness, Treatment [Glaucoma, Stroke, Alzheimer disease, Channel (pression, and Others]), by Age Group (Pediatric, Adult, and Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032 The Citicoline market was valued at USD 0.43 billion in 2023 and ... Read More
-
Global Targeted Drugs for Alzheimer's Disease Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Targeted Drugs for Alzheimer's Disease Industry Forecast” looks at past sales and reviews total world ... Read More
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Global Alzheimer's Treatment Drug Market Growth 2024-2030
... the Alzheimer's Treatment Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Alzheimer's Treatment ... Read More
-
Global Alzheimer's Disease Diagnostic Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Global Alzheimer's Disease Therapeutics and Diagnostics Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various ... Read More
-
Global Blood Tests for Alzheimer's Diagnosis Market Growth (Status and Outlook) 2024-2030
... identify biomarkers associated with Alzheimer's, such as amyloid-beta and tau proteins, which are indicators of the characteristic plaques and tangles in the brain. Advances in technology have made it possible to measure these proteins with ... Read More
-
Global Alzheimer's Blood Tests Market Growth (Status and Outlook) 2024-2030
... beta-amyloid and tau, which are hallmarks of the disease, as well as other indicators of neural damage and inflammation. The development of these tests offers a less invasive and potentially more accessible alternative to traditional ... Read More
-
Alzheimer's Drugs – A Global Market Overview
... 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
Research Assistance
